Tuberculosis Infection Recruiting Phase Trials for Cycloserine (DB00260)

Back to Tuberculosis Infection

Also known as: Tuberculosis (TB) / Tuberculosis / Tuberculous infections / TB / Tuberculosis NOS / Infection TBC / Infection tuberculosis / Tuberculosis (A15-A19)

Indication	Status	Phase
DBCOND0053683 (Tuberculosis Infection)	Recruiting	Not Available

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT04545788	Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis	Treatment	Bedaquiline (DB08903) Cycloserine (DB00260) Linezolid (DB00601)
NCT03625739	Population Pharmacokinetics of Anti-tuberculosis Drugs in Children With Tuberculosis		Amikacin (DB00479) Aminosalicylic acid (DB00233) Amithiozone (DB12829) Amoxicillin (DB01060) Bedaquiline (DB08903) Capreomycin (DB00314) Clavulanic acid (DB00766) Clofazimine (DB00845) Cycloserine (DB00260) Delamanid (DB11637) Ethambutol (DB00330) Ethionamide (DB00609) Gatifloxacin (DB01044) Imipenem (DB01598) Isoniazid (DB00951) Kanamycin (DB01172) Levofloxacin (DB01137) Moxifloxacin (DB00218) Pyrazinamide (DB00339) Rifampicin (DB01045) Streptomycin (DB01082) Terizidone (DB12954)